N

    Neurogene Inc (NGNE)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $36.24
    -0.34 (-0.93%)

    Market Cap: $732.02M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    60%(24/40)
    Avg Surprise
    -167.56%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-1.31
    Range$-1.50 - $-0.96
    6 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate Drift
    90d ago$-1.30+1.1%
    60d ago$-1.31+0.6%
    30d ago$-1.27+3.0%
    7d ago$-1.27+3.0%
    Current$-1.31
    Revenue Consensus
    $0
    Range$0 - $0
    6 analysts
    Dec 31, 2026
    EPS Consensus$-1.70
    Range$-1.93 - $-1.48
    5 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    7 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-1.70---
    Sep 26EST
    		-$-1.31---
    Jun 26
    		$-1.53$-1.40-9.29%Miss-45.7%
    Mar 26
    		$-1.39$-1.27-9.05%Miss-28.4%
    Dec 25
    		$-1.13$-1.24+8.87%Beat-14.1%
    Sep 25
    		$-0.99$-1.09+9.17%Beat+16.8%
    Jun 25
    		$-1.05$-1.16+9.48%Beat+3.7%
    Mar 25
    		$-1.08$-1.12+3.57%Beat-8.0%
    Dec 24
    		$-0.99$-1.13+12.39%Beat+34.4%
    Sep 24
    		$-1.19$-1.22+2.46%Beat-191.9%
    Jun 24
    		$-1.09$-1.03-5.83%Miss-2625.0%
    Mar 24
    		$-1.00$-0.95-5.26%Miss-284.6%
    Dec 23
    		$-1.51$-1.17-29.06%Miss-529.2%
    Sep 23
    		$-0.41$-0.03-1259.00%Miss-69.9%
    Jun 23
    		$-0.04$-0.04+0.00%Beat+85.7%
    Mar 23
    		$-0.26$-0.22-18.18%Miss+7.1%
    Dec 22
    		$-0.24$-0.19-26.32%Miss+14.3%
    Sep 22
    		$-0.24$-0.30+21.13%Beat+14.3%
    Jun 22
    		$-0.28$-0.30+6.67%Beat-3.7%
    Mar 22
    		$-0.28$-0.30+6.04%Beat-3.7%
    Dec 21
    		$-0.28$-0.30+5.31%Beat-27.3%
    Sep 21
    		$-0.28$-0.28-0.61%Miss-600.0%
    Jun 21
    		$-0.27$-0.26-3.05%Miss-35.0%
    Mar 21
    		$-0.27$-0.23-18.42%Miss-50.0%
    Dec 20
    		$-0.22$-0.24+9.95%Beat+4.3%
    Sep 20
    		$-0.04N/A+81.82%Beat+98.2%
    Jun 20
    		$-0.20$-0.21+4.76%Beat-122.2%
    Mar 20
    		$-0.18$-0.23+21.74%Beat-100.0%
    Dec 19
    		$-0.23$-0.28+17.86%Beat-9.5%
    Sep 19
    		$-2.26$-0.04-5550.00%Miss-253.1%
    Jun 19
    		$-0.09$-0.05-80.00%Miss-175.0%
    Mar 19
    		$-0.09N/A+60.87%Beat+85.5%
    Dec 18
    		$-0.21N/A+73.42%Beat+69.6%
    Sep 18
    		$-0.64$-0.21-204.76%Miss-28.0%
    Jun 18
    		$0.12N/A+120.34%Beat+120.3%
    Mar 18
    		$-0.62$-0.66+6.06%Beat-72.2%
    Dec 17
    		$-0.69$-0.57-21.05%Miss-43.7%
    Sep 17
    		$-0.50$-0.59+15.25%Beat-8.7%
    Jun 17
    		$-0.59$-0.51-15.69%Miss-
    Mar 17
    		$-0.36$-0.51+29.41%Beat-
    Dec 16
    		$-0.48$-0.51+5.88%Beat-
    Sep 16
    		$-0.46$-0.58+20.69%Beat-

    Key Metrics

    Valuation
    P/E Ratio-7.20EV/EBITDA-8.02x
    Price/FCF-9.32xFCF Yield-10.73%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-45.30%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio10.64xQuick Ratio10.64x
    Trading Statistics
    Beta1.95Avg Volume209.01K
    52-Week High$43.6652-Week Low$15.93

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$38.13
    SMA 20$37.04
    SMA 50$35.83
    SMA 200$25.88
    EMA 10$37.57
    EMA 20$37.11
    EMA 50$35.24
    EMA 200$28.31

    MACD

    Line: 0.73Signal: 0.90Hist: -0.17

    ADX

    ADX: 15.0+DI: 20.2-DI: 22.0

    Aroon & PSAR

    Aroon Up84.0
    Aroon Down44.0
    PSAR$42.01

    Bollinger Bands

    Upper Band$40.35
    Lower Band$33.72
    %B Position1791%(Upper)
    Band Width0.38

    RSI (14-Day)

    Neutral
    48.3

    Momentum Oscillators

    Stoch %K46.6
    Stoch %D60.7
    Williams %R-76.5
    ROC (10d)-1.2%
    Momentum-0.44
    CCI (20d)-41.3
    MFI (14d)67.6

    Volatility Measures

    ATR (14d)$2.44(6.7%)
    StdDev (20d)1.66
    Hist Vol60.6%(High)

    Volume Flow

    VWAP$36.02
    OBV3.7M
    AD Line579.6K
    CMF (20d)0.243

    Volume Metrics

    Avg Vol (20d)211.7K
    Vol Ratio0.6x
    VWMA (20d)$37.75

    Pivot Points

    R3$40.23
    R2$39.40
    R1$37.99
    Pivot Point$37.15
    S1$35.74
    S2$34.91
    S3$33.50

    Advanced Oscillators

    TSI9.62
    Ultimate Osc43.8
    KST71.16

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$-925,000$0$925,000$0$0$0
    Cost of Revenue$0$0$787,000$0$0$0$15.35M$0$0$0$12.18M$0
    Gross Profit$0$0$-787,000$0$0$0$-15,347,000$0$925,000$0$-12,184,000$0
    Operating Expenses$36.67M$33.35M$27.53M$23.80M$26.08M$25.92M$21.51M$22.18M$21.06M$18.78M$14.73M$15.22M
    R&D$25.47M$25.15M$20.64M$17.24M$19.37M$17.76M$15.35M$16.29M$15.74M$13.54M$12.18M$11.61M
    SG&A$11.20M$8.20M$6.89M$6.56M$6.71M$8.16M$6.17M$5.89M$5.32M$5.24M$2.55M$3.61M
    Operating Income$-36,670,000$-33,349,000$-27,530,000$-23,798,000$-26,081,000$-25,919,000$-21,512,000$-22,180,000$-20,134,000$-18,779,000$-14,733,000$-15,219,000
    Interest Income$2.05M$2.26M$2.67M$2.74M$2.93M$3.21M$2.27M$1.84M$2.04M$2.32M$781,000$650,000
    Interest Expense$0$0$1,000$1,000$1,000$2,000$2,000$3,000$4,000$3,000$3,000$4,000
    Income Before Tax$-34,631,000$-30,934,000$-23,226,000$-21,102,000$-23,228,000$-22,647,000$-19,084,000$-20,360,000$-18,636,000$-17,064,000$-13,972,000$-14,577,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-34,488,000$-30,934,000$-24,735,000$-20,953,000$-22,016,000$-22,647,000$-19,514,000$-20,217,000$-18,492,000$-16,921,000$2.38M$-14,577,000
    EBITDA$-36,201,000$-32,715,000$-25,612,000$-23,880,000$-26,861,000$-26,836,000$-21,513,000$-22,080,000$-20,176,000$-19,002,000$-14,027,000$-15,544,000
    EBIT$-36,677,000$-33,195,000$-25,899,000$-23,840,000$-26,155,000$-25,851,000$-21,352,000$-22,199,000$-20,667,000$-19,381,000$-14,750,000$-15,223,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about NGNE

    News

    Technical Reactions to NGNE Trends in Macro Strategies

    This article analyzes Neoleukin Therapeutics Inc. (NASDAQ: NGNE) using AI models to develop distinct trading strategies. It highlights a strong near-term sentiment potentially leading to a long-term positive bias, with an exceptional risk-reward short setup. The analysis provides specific entry, target, and stop-loss levels for position trading, momentum breakout, and risk hedging strategies.

    Stock Traders Daily•8/16/26•
    Bullish

    (NGNE) Volatility Zones as Tactical Triggers

    This article analyzes Neoleukin Therapeutics Inc. (NASDAQ: NGNE), highlighting weak near-term sentiment but strong mid and long-term outlooks. It identifies a significant 73.1:1 risk-reward short setup and provides specific AI-generated trading strategies for different risk profiles, including position, momentum, and risk hedging. The analysis also details multi-timeframe signal strengths with corresponding support and resistance levels.

    Stock Traders Daily•7/24/26•
    Somewhat-Bearish

    (NGNE) Volatility Zones as Tactical Triggers

    This article analyzes Neoleukin Therapeutics Inc. (NASDAQ: NGNE) using AI models, highlighting strong sentiment across all horizons supporting an overweight bias. It outlines distinct institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored to different risk profiles. The analysis also provides multi-timeframe signal analysis, including support and resistance levels for near-term, mid-term, and long-term horizons.

    Stock Traders Daily•7/12/26•
    Bullish

    Price-Driven Insight from (NGNE) for Rule-Based Strategy

    This article provides a price-driven insight for Neoleukin Therapeutics Inc. (NASDAQ: NGNE) based on AI-generated signals for July 01, 2026. It highlights strong sentiment supporting an overweight bias, an ongoing breakout, and no resistance levels above the current price. The analysis includes institutional trading strategies with specific entry, target, and stop-loss zones for position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis.

    Stock Traders Daily•7/1/26•
    Bullish

    (NGNE) Price Dynamics and Execution-Aware Positioning

    This article analyzes Neoleukin Therapeutics Inc. (NASDAQ: NGNE), highlighting strong sentiment across all horizons supporting an overweight bias. It outlines detailed institutional trading strategies, including long, momentum breakout, and short setups, with specific entry, target, and stop-loss levels. The analysis also provides multi-timeframe signal strengths, support, and resistance levels for near-term, mid-term, and long-term horizons based on AI models.

    Stock Traders Daily•6/20/26•
    Somewhat-Bullish

    Frequently Asked Questions About NGNE

    Does NGNE pay dividends?
    Neurogene Inc (NGNE) does not currently pay a regular dividend.
    What is NGNE's market cap?
    Neurogene Inc (NGNE) has a market capitalization of $732.02M with a current stock price of $36.24.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In